Biote Corp reports results for the quarter ended September 30 - Earnings Summary

What happened

Biote Corp reported adjusted earnings of 1 cent per share for the quarter ended September 30, compared with 22 cents a year earlier and analyst expectations of a 2-cent loss. Revenue fell 9.6% to $43.33 million, below the $45.07 million analysts expected; net income was $407,000.

Confirmed

Global impact / market context

Lower revenue and earnings than a year ago point to weaker business performance, while revenue also missed analysts’ expectations. If that weakness continues, it could limit cash available for operations or investment; the article does not explain what drove the decline or provide forward company guidance.

Analyst inference

Analysts’ average earnings estimate had fallen about 250% over three months, although there were no estimate revisions in the latest 30 days. The shares were down 56.9% year to date, while analysts still averaged a “buy” rating and a $2.00 12-month price target.

Confirmed

What to watch

1. Future quarterly revenue and earnings would show whether the declines persist; stronger results could ease concerns about the business, while further weakness could pressure expectations. Analyst inference
2. Watch for company comments explaining the revenue decline and its plans for spending or operations, since the article gives no cause or forward guidance. Analyst inference
3. Analysts’ next estimate revisions and rating changes could indicate whether expectations adjust to the reported results; the current average rating is “buy,” with four buy recommendations and one hold. Confirmed

Evidence

• Original source link unavailable